| Fund Name | Location |
| Aldrich Capital Partners | Bethesda, Maryland, United States |
| Arm Accelerator | Beijing, Beijing, China |
| Baotou Yunheng | Baotou City, China, Inner Mongolia |
| Entangled Ventures | California, San Francisco, United States |
| Inflection Ventures | Central, Central Region, Singapore |
| IngDan International | China, Guangdong, Shenzhen |
| Lakson Investments Venture Capital | Karachi, Pakistan, Sindh |
| Laurel Crown Partners | California, Los Angeles, United States |
| LF Capital | Beijing, Beijing, China |
| NewSpring Capital | Pennsylvania, Radnor, United States |
| QNBEYOND Ventures | - |
| Shri Investments | - |
| Simplex Investments | Chicago, Illinois, United States |
| SORITA PLUS | - |
| Steel Dynamics | Fort Wayne, Indiana, United States |
| Suez Nederland | - |
| Tenzing | England, London, United Kingdom |
| Ysios Capital | Barcelona, Catalonia, Spain |
| Zeal Investments | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Lanboto | $15M | 13 Jul 2023 | Nanjing, Jiangsu, China | ||
PolarisIC | $13M | 14 Dec 2022 | Wuhan, Hubei, China | ||
Novlead Biotech | 01 Jan 2021 | Nanjing, Jiangsu, China | |||
InxMed | $20M | 04 Sep 2020 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Lanboto | $15M | 13 Jul 2023 | Nanjing, Jiangsu, China | ||
PolarisIC | $13M | 14 Dec 2022 | Wuhan, Hubei, China | ||
Novlead Biotech | 01 Jan 2021 | Nanjing, Jiangsu, China | |||
InxMed | $20M | 04 Sep 2020 | Shanghai, China |
